A patient with a germline SDHB mutation presenting with an isolated pituitary macroprolactinoma
Symptomatic pituitary adenomas occur with a prevalence of approximately 0.1% in the general population. It is estimated that 5% of pituitary adenomas occur in a familial setting, either in isolated or syndromic form. Recently, loss-of-function mutations in genes encoding succinate dehydrogenase subu...
Auteurs principaux: | Michelle Maher, Federico Roncaroli, Nigel Mendoza, Karim Meeran, Natalie Canham, Monika Kosicka-Slawinska, Birgitta Bernhard, David Collier, Juliana Drummond, Kassiani Skordilis, Nicola Tufton, Anastasia Gontsarova, Niamh Martin, Márta Korbonits, Florian Wernig |
---|---|
Format: | Article |
Langue: | English |
Publié: |
Bioscientifica
2018-07-01
|
Collection: | Endocrinology, Diabetes & Metabolism Case Reports |
Accès en ligne: | https://www.edmcasereports.com/articles/endocrinology-diabetes-and-metabolism-case-reports/10.1530/EDM-18-0078 |
Documents similaires
-
An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline SDHB pathogenic variant in the absence of paraganglioma or pheochromocytoma
par: Ali S. Alzahrani, et autres
Publié: (2023-12-01) -
Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
par: Lambert, K, et autres
Publié: (2017) -
Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
par: Lambert, K, et autres
Publié: (2017) -
Germline SDHB and SDHD mutations in pheochromocytoma and paraganglioma patients
par: Yiqiang Huang, et autres
Publié: (2018-11-01) -
Use of SDHB immunohistochemistry to identify germline mutations of SDH genes
par: Gill AJ
Publié: (2012-04-01)